In September 2022, AnGes decides discontinuation of development of DNA vaccine for original Wuhan strain of COVID-19
and start of research into improved DNA vaccine for COVID-19 Variants and Formulation for its intranasal delivery.

Information on COVID-19

It was decided that we should utilize the plasmid DNA technology developed by our company as quickly as possible to respond the urgent global challenge of preventing the spread of COVID-19 and formulate effective solutions; accordingly, we announced "Joint Development of a DNA Vaccine to Combat the Covid-19" on March 5, 2020.
Relevant information, including the matters we have worked on since the announcement, and answers to the questions we have received are set out below.

[DNA vaccine for COVID-19]

The DNA vaccine against COVID-19 is a plasmid DNA vaccine encoding the SARS-CoV-2 spike protein that opens the door to infection. It is expected to prevent COVID-19 or the condition of COVID-19 patients from deteriorating. Since the vaccine is engineered to express only the spikes on the viral surface, thereby producing antibodies, it is nonpathogenic and safe.

What are viruses?

What are DNA vaccines?